Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer
ByYoshinari Ono, MD, PhD,Ohinichi Ohshima, MD, PhD,Yoshito Takahashi, MD, PhD,Manabu Kuriyama, MD, PhD,Yukimichi Kawada, MD, PhD
Published: | Updated:
A prospective, randomized clinical trial was conducted to evaluate the efficacy of endocrine chemotherapy with uracil and tegafur (in a molar ratio of 4:1 [UFT]) in patients with prostate cancer. The study included two